Company

MABVAX THERAPEUTICS HOLDINGS, INC. (0001109196)

Standardized SEC financial data for MABVAX THERAPEUTICS HOLDINGS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001109196 · Pharmaceutical Preparations.

Revenue growth (YoY)

-100.0%

Return on equity

-1000.0%

ROIC

-368.8%

Free cash flow

-$11.0M

Debt / equity

3.21×

Current ratio

0.21×

Ratios for fiscal year 2017, standardized from SEC filings.

Income statement

USD	FY2016	FY2017
Revenue	$148K	$0
R&D expense	$7.8M	$7.5M
SG&A expense	$9.0M	$10.5M
Operating income	-$16.7M	-$18.1M
Interest expense	$997K	$929K
Income tax	$0	$0
Net income

Balance sheet

USD	FY2016	FY2017
Cash & equivalents	$4.0M	$886K
Total current assets	$4.3M	$1.2M
Property, plant & equipment	$732K	$578K
Goodwill	$6.8M	$6.8M
Total assets	$12.0M	$8.8M
Total current liabilities	$5.7M	$5.8M
Long-term debt

Cash flow

USD	FY2016	FY2017
Operating cash flow	-$12.4M	-$11.0M
Capital expenditures	$563K	$21K
Free cash flow	-$12.9M	-$11.0M
Investing cash flow	-$563K	-$21K
Financing cash flow	$12.8M	$7.9M
Dividends paid	$0	$0

Get 0001109196 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001109196/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001109196/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001109196 filings on SEC EDGAR →